Fintel reports that on September 8, 2023, Alliance Global Partners initiated coverage of Nano X Imaging (NASDAQ:NNOX) with a Buy recommendation.
Analyst Price Forecast Suggests 337.53% Upside
As of August 31, 2023, the average one-year price target for Nano X Imaging is 32.64. The forecasts range from a low of 30.30 to a high of $35.70. The average price target represents an increase of 337.53% from its latest reported closing price of 7.46.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Nano X Imaging is 21MM, an increase of 122.94%. The projected annual non-GAAP EPS is -1.50.
What is the Fund Sentiment?
There are 195 funds or institutions reporting positions in Nano X Imaging. This is a decrease of 3 owner(s) or 1.52% in the last quarter. Average portfolio weight of all funds dedicated to NNOX is 0.06%, an increase of 53.99%. Total shares owned by institutions increased in the last three months by 17.58% to 13,345K shares. 
The put/call ratio of NNOX is 0.49, indicating a bullish outlook.
What are Other Shareholders Doing?
IWM - iShares Russell 2000 ETF holds 1,051K shares representing 1.82% ownership of the company. In it's prior filing, the firm reported owning 992K shares, representing an increase of 5.67%. The firm increased its portfolio allocation in NNOX by 162.35% over the last quarter.
Credit Suisse holds 687K shares representing 1.19% ownership of the company. In it's prior filing, the firm reported owning 678K shares, representing an increase of 1.27%. The firm increased its portfolio allocation in NNOX by 1,041.92% over the last quarter.
Geode Capital Management holds 526K shares representing 0.91% ownership of the company. In it's prior filing, the firm reported owning 490K shares, representing an increase of 6.85%. The firm increased its portfolio allocation in NNOX by 160.81% over the last quarter.
Vk Services holds 427K shares representing 0.74% ownership of the company. No change in the last quarter.
FSSNX - Fidelity Small Cap Index Fund holds 398K shares representing 0.69% ownership of the company. In it's prior filing, the firm reported owning 378K shares, representing an increase of 4.95%. The firm decreased its portfolio allocation in NNOX by 26.38% over the last quarter.
Nano X Imaging Background Information
(This description is provided by the company.)
Nano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.
Additional reading:
- Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update Reports progress towards global supply chain development Ended the second quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of
- A.G.P./Alliance Global Partners 590 Madison Avenue, 28th Floor New York, NY 10022
- SECURITIES PURCHASE AGREEMENT
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
